首页> 外文期刊>Bone marrow transplantation >Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy?: real-world experience and cost analysis in India
【24h】

Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy?: real-world experience and cost analysis in India

机译:Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy?: real-world experience and cost analysis in India

获取原文
获取原文并翻译 | 示例
           

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号